Table of contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Cancer (2023), by Type and Region
5.2 Adoption of Oncology Companion Diagnostics (2023), by Region and Cancer Type
5.3 Healthcare Spending on Oncology Companion Diagnostics, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
5.4 Biomarker-Specific Market Trends and Test Adoption (2023)
5.5 Laboratory and Point-of-Care Testing Trends (2023-2032)
5.6 Partnership and Collaborations in Companion Diagnostics (2023)
5.7 Market Trends in Emerging Technologies for Companion Diagnostics (2023-2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and Promotional Activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Oncology Companion Diagnostic Market Segmentation, by Product & Services
7.1 Chapter Overview
7.2 Product
7.2.1 Product Market Trends Analysis (2020-2032)
7.2.2 Product Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Instrument
7.2.3.1 Instrument Market Trends Analysis (2020-2032)
7.2.3.2 Instrument Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Consumables
7.2.4.1 Consumables Market Trends Analysis (2020-2032)
7.2.4.2 Consumables Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Software
7.2.5.1 Software Market Trends Analysis (2020-2032)
7.2.5.2 Software Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Services
7.3.1 Services Market Trends Analysis (2020-2032)
7.3.2 Services Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Oncology Companion Diagnostic Market Segmentation, By Technology
8.1 Chapter Overview
8.2 Polymerase Chain Reaction (PCR)
8.2.1 Polymerase Chain Reaction (PCR) Market Trends Analysis (2020-2032)
8.2.2 Polymerase Chain Reaction (PCR) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Next-generation Sequencing (NGS)
8.3.1 Next-generation Sequencing (NGS) Market Trends Analysis (2020-2032)
8.3.2 Next-generation Sequencing (NGS) Market Size Estimates And Forecasts To 2032 (USD Billion)
8.4 Immunohistochemistry (IHC)
8.4.1 Immunohistochemistry (IHC) Market Trends Analysis (2020-2032)
8.4.2 Immunohistochemistry (IHC) Market Size Estimates And Forecasts To 2032 (USD Billion)
8.5 In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization (FISH)
8.5.1 In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization (FISH) Market Trends Analysis (2020-2032)
8.5.2 In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization (FISH) Market Size Estimates And Forecasts To 2032 (USD Billion)
8.6 Other Technologies
8.6.1 Other Technologies Market Trends Analysis (2020-2032)
8.6.2 Other Technologies Market Size Estimates And Forecasts To 2032 (USD Billion)
9. Oncology Companion Diagnostic Market Segmentation, by Disease Type
9.1 Chapter Overview
9.2 Breast Cancer
9.2.1 Breast Cancer Market Trends Analysis (2020-2032)
9.2.2 Breast Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Non-small Cell Lung Cancer
9.3.1 Non-small Cell Lung Cancer Market Trends Analysis (2020-2032)
9.3.2 Non-small Cell Lung Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Colorectal Cancer
9.4.1 Colorectal Cancer Market Trends Analysis (2020-2032)
9.4.2 Colorectal Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Leukemia
9.5.1 Leukemia Market Trends Analysis (2020-2032)
9.5.2 Leukemia Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Melanoma
9.6.1 Melanoma Market Trends Analysis (2020-2032)
9.6.2 Melanoma Market Size Estimates and Forecasts to 2032 (USD Billion)
9.7 Prostate Cancer
9.7.1 Prostate Cancer Market Trends Analysis (2020-2032)
9.7.2 Prostate Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
9.8 Others
9.8.1 Others Market Trends Analysis (2020-2032)
9.8.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Oncology Companion Diagnostic Market Segmentation, By End Use
10.1 Chapter Overview
10.2 Hospital
10.2.1 Hospital Market Trends Analysis (2020-2032)
10.2.2 Hospital Market Size Estimates and Forecasts to 2032 (USD Billion)
10.3 Pathology/Diagnostic Laboratory
10.3.1 Pathology/Diagnostic Laboratory Market Trends Analysis (2020-2032)
10.3.2 Pathology/Diagnostic Laboratory Market Size Estimates and Forecasts to 2032 (USD Billion)
10.4 Academic Medical Center
10.4.1 Academic Medical Center Market Trends Analysis (2020-2032)
10.4.2 Academic Medical Center Market Size Estimates and Forecasts to 2032 (USD Billion)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trends Analysis
11.2.2 North America Oncology Companion Diagnostic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.2.3 North America Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.2.4 North America Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.2.5 North America Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.2.6 North America Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.2.7 USA
11.2.7.1 USA Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.2.7.2 USA Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.2.7.3 USA Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.2.7.4 USA Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.2.8 Canada
11.2.8.1 Canada Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.2.8.2 Canada Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.2.8.3 Canada Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.2.8.4 Canada Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.2.9 Mexico
11.2.9.1 Mexico Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.2.9.2 Mexico Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.2.9.3 Mexico Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.2.9.4 Mexico Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Trends Analysis
11.3.1.2 Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.1.3 Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.1.4 Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.1.5 Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.1.6 Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.1.7 Poland
11.3.1.7.1 Poland Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.1.7.2 Poland Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.1.7.3 Poland Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.1.7.4 Poland Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.1.8 Romania
11.3.1.8.1 Romania Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.1.8.2 Romania Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.1.8.3 Romania Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.1.8.4 Romania Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.1.9 Hungary
11.3.1.9.1 Hungary Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.1.9.2 Hungary Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.1.9.3 Hungary Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.1.9.4 Hungary Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.1.10 Turkey
11.3.1.10.1 Turkey Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.1.10.2 Turkey Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.1.10.3 Turkey Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.1.10.4 Turkey Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.1.11 Rest of Eastern Europe
11.3.1.11.1 Rest of Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.1.11.2 Rest of Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.1.11.3 Rest of Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.1.11.4 Rest of Eastern Europe Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2 Western Europe
11.3.2.1 Trends Analysis
11.3.2.2 Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.2.3 Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.4 Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
11.3.2.5 Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Delivery Mode (2020-2032) (USD Billion)
11.3.2.6 Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.7 Germany
11.3.2.7.1 Germany Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.7.2 Germany Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.7.3 Germany Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.7.4 Germany Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.8 France
11.3.2.8.1 France Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.8.2 France Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.8.3 France Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.8.4 France Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.9 UK
11.3.2.9.1 UK Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.9.2 UK Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.9.3 UK Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.9.4 UK Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.10 Italy
11.3.2.10.1 Italy Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.10.2 Italy Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.10.3 Italy Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.10.4 Italy Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.11 Spain
11.3.2.11.1 Spain Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.11.2 Spain Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.11.3 Spain Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.11.4 Spain Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.12 Netherlands
11.3.2.12.1 Netherlands Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.12.2 Netherlands Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.12.3 Netherlands Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.12.4 Netherlands Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.13 Switzerland
11.3.2.13.1 Switzerland Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.13.2 Switzerland Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.13.3 Switzerland Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.13.4 Switzerland Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.14 Austria
11.3.2.14.1 Austria Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.14.2 Austria Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.14.3 Austria Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.14.4 Austria Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.3.2.15 Rest of Western Europe
11.3.2.15.1 Rest of Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.3.2.15.2 Rest of Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.3.2.15.3 Rest of Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.3.2.15.4 Rest of Western Europe Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4 Asia Pacific
11.4.1 Trends Analysis
11.4.2 Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.4.3 Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.4 Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.5 Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.6 Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4.7 China
11.4.7.1 China Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.7.2 China Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.7.3 China Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.7.4 China Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4.8 India
11.4.8.1 India Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.8.2 India Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.8.3 India Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.8.4 India Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4.9 Japan
11.4.9.1 Japan Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.9.2 Japan Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.9.3 Japan Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.9.4 Japan Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4.10 South Korea
11.4.10.1 South Korea Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.10.2 South Korea Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.10.3 South Korea Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.10.4 South Korea Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4.11 Vietnam
11.4.11.1 Vietnam Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.11.2 Vietnam Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.11.3 Vietnam Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.11.4 Vietnam Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4.12 Singapore
11.4.12.1 Singapore Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.12.2 Singapore Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.12.3 Singapore Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.12.4 Singapore Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4.13 Australia
11.4.13.1 Australia Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.13.2 Australia Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.13.3 Australia Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.13.4 Australia Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.4.14 Rest of Asia Pacific
11.4.14.1 Rest of Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.4.14.2 Rest of Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.4.14.3 Rest of Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.4.14.4 Rest of Asia Pacific Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5 Middle East and Africa
11.5.1 Middle East
11.5.1.1 Trends Analysis
11.5.1.2 Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.1.3 Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.1.4 Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.1.5 Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.1.6 Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.1.7 UAE
11.5.1.7.1 UAE Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.1.7.2 UAE Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.1.7.3 UAE Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.1.7.4 UAE Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.1.8 Egypt
11.5.1.8.1 Egypt Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.1.8.2 Egypt Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.1.8.3 Egypt Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.1.8.4 Egypt Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.1.9 Saudi Arabia
11.5.1.9.1 Saudi Arabia Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.1.9.2 Saudi Arabia Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.1.9.3 Saudi Arabia Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.1.9.4 Saudi Arabia Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.1.10 Qatar
11.5.1.10.1 Qatar Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.1.10.2 Qatar Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.1.10.3 Qatar Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.1.10.4 Qatar Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.1.11 Rest of Middle East
11.5.1.11.1 Rest of Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.1.11.2 Rest of Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.1.11.3 Rest of Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.1.11.4 Rest of Middle East Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.2 Africa
11.5.2.1 Trends Analysis
11.5.2.2 Africa Oncology Companion Diagnostic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.2.3 Africa Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.2.4 Africa Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.2.5 Africa Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.2.6 Africa Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.2.7 South Africa
11.5.2.7.1 South Africa Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.2.7.2 South Africa Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.2.7.3 South Africa Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.2.7.4 South Africa Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.2.8 Nigeria
11.5.2.8.1 Nigeria Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.2.8.2 Nigeria Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.2.8.3 Nigeria Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.2.8.4 Nigeria Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.5.2.9 Rest of Africa
11.5.2.9.1 Rest of Africa Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.5.2.9.2 Rest of Africa Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.5.2.9.3 Rest of Africa Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.5.2.9.4 Rest of Africa Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.6 Latin America
11.6.1 Trends Analysis
11.6.2 Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.6.3 Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.6.4 Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.6.5 Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.6.6 Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.6.7 Brazil
11.6.7.1 Brazil Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.6.7.2 Brazil Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.6.7.3 Brazil Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.6.7.4 Brazil Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.6.8 Argentina
11.6.8.1 Argentina Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.6.8.2 Argentina Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.6.8.3 Argentina Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.6.8.4 Argentina Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.6.9 Colombia
11.6.9.1 Colombia Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.6.9.2 Colombia Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.6.9.3 Colombia Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.6.9.4 Colombia Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, by Product & Services (2020-2032) (USD Billion)
11.6.10.2 Rest of Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
11.6.10.3 Rest of Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, by Disease Type (2020-2032) (USD Billion)
11.6.10.4 Rest of Latin America Oncology Companion Diagnostic Market Estimates and Forecasts, By End Use (2020-2032) (USD Billion)
12. Company Profiles
12.1 Agilent Technologies, Inc.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Product / Services Offered
12.1.4 SWOT Analysis
12.2 Illumina, Inc.
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Product / Services Offered
12.2.4 SWOT Analysis
12.3 QIAGEN
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Product / Services Offered
12.3.4 SWOT Analysis
12.4 Thermo Fisher Scientific Inc.
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Product / Services Offered
12.4.4 SWOT Analysis
12.5 Foundation Medicine, Inc.
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Product / Services Offered
12.5.4 SWOT Analysis
12.6 Myriad Genetics, Inc.
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Product / Services Offered
12.6.4 SWOT Analysis
12.7 F. Hoffmann-La Roche Ltd.
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Product / Services Offered
12.7.4 SWOT Analysis
12.8 BioMérieux
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Product / Services Offered
12.8.4 SWOT Analysis
12.9 Leica Biosystems
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Product / Services Offered
12.9.4 SWOT Analysis
12.10 Abbott
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Product / Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
